Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CorMedix (CRMD) Interest Expenses (2016 - 2025)

CorMedix has reported Interest Expenses over the past 13 years, most recently at $1.8 million for Q4 2025.

  • Quarterly results put Interest Expenses at $1.8 million for Q4 2025, up 18823.96% from a year ago — trailing twelve months through Dec 2025 was $2.8 million (up 7627.78% YoY), and the annual figure for FY2025 was $2.8 million, up 7627.78%.
  • Interest Expenses reached $1.8 million in Q4 2025 per CRMD's latest filing, up from $948242.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $1.8 million in Q4 2025 and bottomed at $3585.0 in Q2 2022.
  • Median Interest Expenses over the past 5 years was $8775.0 (2022), compared with a mean of $152355.4.
  • The largest annual shift saw Interest Expenses crashed 31.01% in 2021 before it soared 18823.96% in 2025.
  • Over 5 years, Interest Expenses stood at $5378.0 in 2021, then soared by 63.16% to $8775.0 in 2022, then decreased by 25.29% to $6556.0 in 2023, then skyrocketed by 46.46% to $9602.0 in 2024, then skyrocketed by 18823.96% to $1.8 million in 2025.
  • Business Quant data shows Interest Expenses for CRMD at $1.8 million in Q4 2025, $948242.0 in Q3 2025, and $6671.0 in Q2 2025.